Nektar Management To Present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA Nektar (Nasdaq: NKTR) management is scheduled to present at the upcoming 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, ...
Wednesday, January 3, 2024 BiopharmaWatch Research 1 min read
Key Takeaway: Nektar Therapeutics is scheduled to present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on January 10, 2024. The management's presentation will take place at 5:15 p.m. Pacific Time and will include a Q&A session. Investors and interested parties can access the presentation via a webcast that will be available for replay until February 9, 2024. Nektar is known for its extensive R&D pipeline focused on oncology and immunology.
Price reaction · baseline $8.922 (2024-01-02 close) · hit after-hours · clean, no other NKTR news in the window
day 0 close · peak
-6.4%
day 1
-5%
day 3
-1.3%
Market Sentiment Analysis
POSITIVE FACTORS
Nektar is set to present at a prominent healthcare conference.
The company has a robust and fully owned R&D pipeline in key therapeutic areas.
The presentation will be accessible to a wide audience via webcast.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+186%
120-day peak, hindsight
Typical move
10.2%
average across 4 past catalysts
Cash runway
~40 mo
Minimal dilution risk
Lead asset
Rezpegaldesleukin
Phase 3 · Moderate-to-Severe Atopic Dermatitis
Full Press Release Details
SAN FRANCISCO , Jan. 3, 2024 /PRNewswire/ -- Nektar (Nasdaq: NKTR ) management is scheduled to present at the upcoming 42 nd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 10, 2024 at 5:15 p.m. Pacific Time. The presentation and Q&A session will be accessible via a Webcast through a link posted on the Investor Events Calendar section of the Nektar website: https://ir.nektar.com/events-and-presentations/events . This webcast will be available for replay until February 9, 2024 .
Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology and immunology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California , with additional operations in Huntsville, Alabama . Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com .
Frequently Asked Questions
When is Nektar's presentation at the J.P. Morgan Healthcare Conference?
Nektar's presentation is on January 10, 2024, at 5:15 p.m. Pacific Time.
How can I access Nektar's presentation webcast?
The webcast can be accessed through the Investor Events Calendar on Nektar's website.
Until when will the webcast replay be available?
The webcast will be available for replay until February 9, 2024.
What areas does Nektar's R&D pipeline focus on?
Nektar's R&D pipeline focuses on oncology and immunology investigational medicines.
Where is Nektar Therapeutics headquartered?
Nektar Therapeutics is headquartered in San Francisco, California.